Pulse Biosciences (PLSE) Long-Term Debt Issuances (2021)
Pulse Biosciences' quarterly Long-Term Debt Issuances came in at -$1.9 million in Q4 2021, down 1027.75% quarter-over-quarter from $209000.0 in Q3 2021.
Pulse Biosciences has reported Long-Term Debt Issuances for 1 years, with the latest figure at -$1.9 million in Q4 2021.
- For the quarter ending Q4 2021, Long-Term Debt Issuances changed N/A year-over-year to -$1.9 million; the trailing twelve-month figure through Dec 2023 stood at -$1.7 million (up 95.78% YoY), and the FY2022 full-year result was $65.0 million, changed N/A from the prior year.
- Long-Term Debt Issuances for Q4 2021 stood at -$1.9 million, down from $209000.0 in the prior quarter.
- The five-year high for Long-Term Debt Issuances was $41.0 million in Q1 2021, with the low at -$39.3 million in Q2 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | - |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | - |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | - |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 46.00 Mn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 875.40 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | - |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | - |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 5.04 Mn |
| 10 | Pulse Biosciences | 1.72 Bn | 1.72 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -1.94 Mn |
| Dec 31, 2021 | -1.94 Mn |
| Sep 30, 2021 | 209,000.00 |
| Sep 30, 2021 | 209,000.00 |
| Jun 30, 2021 | -39.27 Mn |
| Jun 30, 2021 | -39.27 Mn |
| Mar 31, 2021 | 41.00 Mn |
| Mar 31, 2021 | 41.00 Mn |